<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0748902" disease_type="Disease or Syndrome" abbrv="">spinal cord infarction</z:e> is a rare cause of <z:hpo ids='HP_0011009'>acute-onset</z:hpo> <z:hpo ids='HP_0010550'>paraplegia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Furthermore, it is specially uncommon that the infarction occurs in patients with apparent low predisposition to <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The 20210A allele of the prothrombin gene (causing a threefold-increased risk in venous <z:hpo ids='HP_0001907'>thromboembolism</z:hpo>) was recently associated with unexplained <z:e sem="disease" ids="C0748902" disease_type="Disease or Syndrome" abbrv="">spinal cord infarction</z:e> in young women under treatment with <z:chebi fb="1" ids="50114">estrogens</z:chebi> (contraceptive pill) </plain></SENT>
<SENT sid="3" pm="."><plain>We report a case of <z:e sem="disease" ids="C0221069" disease_type="Disease or Syndrome" abbrv="">anterior spinal artery syndrome</z:e> resulting from an ischaemic infarction at the anterior aspect of the spinal cord in a healthy 50-year-old woman, carrying this mutation, being the first published case under treatment with transdermal <z:chebi fb="1" ids="23965">estradiol</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>She referred the typical sudden-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:hpo ids='HP_0003418'>back pain</z:hpo> associated to clinical <z:e sem="disease" ids="C0221069" disease_type="Disease or Syndrome" abbrv="">anterior spinal artery syndrome</z:e> with sphincter dysfunction and nontraumatic <z:hpo ids='HP_0010550'>paraplegia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>A possible multiple <z:mp ids='MP_0000612'>sclerosis</z:mp> was ruled out and the steroids or immunoglobulin therapy induced no clinical improvement </plain></SENT>
<SENT sid="6" pm="."><plain>Cerebrospinal fluid and other investigations were <z:hpo ids='HP_0000001'>all</z:hpo> negative </plain></SENT>
<SENT sid="7" pm="."><plain>Sequential MRI scans revealed development of <z:e sem="disease" ids="C0748902" disease_type="Disease or Syndrome" abbrv="">spinal cord infarction</z:e> from T10 to T11, with increased signal in T2-weighted image (T2) </plain></SENT>
<SENT sid="8" pm="."><plain>Because she referred a previous <z:hpo ids='HP_0004418'>thrombophlebitis</z:hpo> and suffered a <z:hpo ids='HP_0002625'>deep-vein thrombosis</z:hpo> one month after <z:hpo ids='HP_0010550'>paraplegia</z:hpo>, a complete coagulation study was performed </plain></SENT>
<SENT sid="9" pm="."><plain>Antithrombin, proteins C and S, <z:chebi fb="0" ids="17230">homocysteine</z:chebi>, factor V Leiden, <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and anticardiolipin antibodies were <z:hpo ids='HP_0000001'>all</z:hpo> <z:mpath ids='MPATH_458'>normal</z:mpath> or negatives </plain></SENT>
<SENT sid="10" pm="."><plain>In opposite, the 20210A variation was positive (heterozygous) and the factor VIIIc level was very high (280 U/dl eight months later) </plain></SENT>
<SENT sid="11" pm="."><plain>We argue the relative importance of both findings </plain></SENT>
<SENT sid="12" pm="."><plain>The patient had no a substantial recovery over a period of 20 months.Certainly, the prothrombin 20210A seems to be associated with unexplained ischemic <z:hpo ids='HP_0002196'>myelopathy</z:hpo> among the young women with <z:chebi fb="1" ids="50114">estrogens</z:chebi> </plain></SENT>
</text></document>